Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
TNGX | Tango Therapeutics, Inc. | Chief Executive Officer, Director | $19.4 M | -$115 K | -0.59% | Feb 6, 2024 |
RVMD | Revolution Medicines, Inc. | Director | $772 K | -$526 K | -40.5% | Jun 20, 2024 |
OHAA, OHAAU | Opy Acquisition Corp. I | Director | Oct 26, 2021 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|